Skip to main content
Premium Trial:

Request an Annual Quote

Integrated DNA Technologies, ChosenMed Technology to Develop Gene Panels for Chinese Cancer Project

NEW YORK – Integrated DNA Technologies and Chinese medical sequencing firm ChosenMed are jointly developing large pan-cancer gene panels as part of the Cancer Genome Atlas of China (CGAC) project, IDT said today.

Under the strategic collaboration, IDT, a unit of Danaher, will provide its next-generation sequencing enrichment products for cancer sequencing to Beijing-based ChosenMed and help to enhance the firm's R&D capabilities.

Financial details of the agreement were not disclosed.

"This strategic cooperation allows our two organizations to leverage expertise in a joint effort to address future clinical needs," IDT President Trey Martin said in a statement.

IDT said the CGAC project, which is led by a Chinese government department that provides national standards for the registration of medical devices, has identified a clinical need for a large pan-cancer panel to standardize cancer diagnoses for Chinese patients. The two companies "will work together to build and develop future standards for NGS-based cancer diagnosis and, ultimately, treatment in China," according to IDT.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.